Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm?

Diagn Pathol. 2021 Nov 20;16(1):108. doi: 10.1186/s13000-021-01165-5.

Abstract

Background: Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) of the pancreas are extremely rare. Their pathogenesis and molecular landscape are largely unknown. Here, we report a case of mixed pancreatic intraductal papillary mucinous neoplasm (IPMN) and well-differentiated neuroendocrine tumor (NET) and identify its genetic alterations by next-generation sequencing (NGS).

Case presentation: A fifty-year-old male was admitted into the hospital for evaluation of a pancreatic lesion detected during a routine examination. Abdominal ultrasound indicated a hypoechoic mass of 2.6 cm at the head of the pancreas. Malignancy was suspected and partial pancreatectomy was performed. Thorough histopathological examination revealed a mixed IPMN-NET. In some areas, the two components were relatively separated, whereas in other areas IPMN and NET grew in a composite pattern: The papillae were lined with epithelial cells of IPMN, and there were clusters of NET nests in the stroma of papillary axis. NGS revealed shared somatic mutations (KRAS, PCK1, MLL3) in both components. The patient has been uneventful 21 months after the surgery.

Conclusions: Our case provides evidence of a common origin for mixed IPMN-NET with composite growth features. Our result and literature review indicate that KRAS mutation might be a driver event underlying the occurrence of MiNEN. We also recommend the inclusion of mixed non-invasive exocrine neoplasms and neuroendocrine neoplasms into MiNEN.

Keywords: Case report; Composite; KRAS; MiNEN.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Biomarkers, Tumor / genetics
  • Carcinoma, Neuroendocrine / genetics
  • Carcinoma, Neuroendocrine / pathology*
  • Carcinoma, Neuroendocrine / surgery
  • Cell Differentiation
  • DNA Mutational Analysis
  • DNA-Binding Proteins / genetics
  • Genetic Predisposition to Disease
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Intracellular Signaling Peptides and Proteins / genetics
  • Male
  • Middle Aged
  • Mutation
  • Neoplasms, Complex and Mixed / genetics
  • Neoplasms, Complex and Mixed / pathology*
  • Neoplasms, Complex and Mixed / surgery
  • Pancreatectomy
  • Pancreatic Intraductal Neoplasms / genetics
  • Pancreatic Intraductal Neoplasms / pathology*
  • Pancreatic Intraductal Neoplasms / surgery
  • Pancreatic Neoplasms / genetics
  • Pancreatic Neoplasms / pathology*
  • Pancreatic Neoplasms / surgery
  • Phenotype
  • Phosphoenolpyruvate Carboxykinase (GTP) / genetics
  • Proto-Oncogene Proteins p21(ras) / genetics
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • DNA-Binding Proteins
  • Intracellular Signaling Peptides and Proteins
  • KMT2C protein, human
  • KRAS protein, human
  • Proto-Oncogene Proteins p21(ras)
  • PCK1 protein, human
  • Phosphoenolpyruvate Carboxykinase (GTP)